Recently stock market analysts have updated their consensus ratings on shares of Bioanalytical Systems, Inc. (BASI). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

02/21/2014 – Bioanalytical Systems, Inc. was downgraded to “sell” by analysts at TheStreet.

12/02/2013 – Bioanalytical Systems, Inc. was downgraded to “hold” by analysts at Thomson Reuters/Verus.

Bioanalytical Systems, Inc. has a 50 day moving average of 1.08 and a 200 day moving average of 1.37. The stock’s market capitalization is 8.19M, it has a 52-week low of 1.00 and a 52-week high of 2.20.

The share price of the company (BASI) was up +0.00% during the last trading session, with a high of 1.04 and the volume of Bioanalytical Systems, Inc. shares traded was 889.

View other investors thoughts on Bioanalytical Systems, Inc. on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.